Top Markets
#1 Black Phoenix Black Phoenix +350.66%
#2 Islamic Coin Islamic Coin +158.09%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.42%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.26%
#6 DOVU DOVU +16.40%
#7 Pons Pons +8.78%
#8 stake.link stake.link +8.32%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +7.32%
#10 COTI COTI +6.82%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Invictus MD Strategies Corp. Invictus MD Strategies Corp.

Invictus MD Strategies Corp.

IVITF
Rank in Stocks #41813
Invictus MD Strategies Corp. is a Canadian firm primarily focused on strategic... Invictus MD Strategies Corp. is a Canadian firm primarily focused on strategic investments, acquisitions, and the development of complementary enterprises within the country's cannabis sector. The company's operations are divided into two main areas: cannabis sales and fertilizers. Its cannabis division is involved in the cultivation and distribution of medical cannabis. Concurrently, its fertilizer segment offers hydroponic plant fertilizers, nutrient solutions, and various other supplies essential for cultivation. Additionally, Invictus MD Strategies Corp. manages medical clinics situated in Alberta. The company was established in 2014 and maintains its principal office in Vancouver, Canada.
Share Price
$0.0001
Last synced: 2025-05-28
Market Cap
$9.77K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CA
Trade Invictus MD Strategies Corp. (IVITF)

Category

Healthcare
Revenue for Invictus MD Strategies Corp. (IVITF)
Revenue in Oct 2019 TTM: $4.63M
According to Invictus MD Strategies Corp. latest financial reports the company's current revenue (TTM) is $4.63M. In 2018 the company made a revenue of $1.57M an increase over the revenue in the year 2017 that was $1.50M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Invictus MD Strategies Corp. from 2014 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $4.63M 70.08%
2019 $2.72M 73.79%
2018 $1.57M 4.46%
2017 $1.50M -20.40%
2016 $1.88M 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B 142,701.75%
IN